Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2019-09-11 4:55 pm Purchase | 13D | CERECOR INC CERC | ARMISTICE CAPITAL LLC | 39,368,948 64.3% | 2,538,948 (+6.89%) | View |
2019-09-06 5:21 pm Purchase | 13G | SOPHIRIS BIO INC SPHS | ARMISTICE CAPITAL LLC | 2,538,463 7.6% | 2,538,463 (New Position) | View |
2019-08-26 5:20 pm Purchase | 13G | BELLICUM PHARMACEUTICALS INC C BLCM | ARMISTICE CAPITAL LLC | 3,232,419 6.5% | 3,232,419 (New Position) | View |
2019-08-26 5:09 pm Purchase | 13G | DIPLOMAT PHARMACY INC DPLO | ARMISTICE CAPITAL LLC | 4,310,000 5.7% | 4,310,000 (New Position) | View |
2019-08-19 5:13 pm Purchase | 13G | NOVABAY PHARMACEUTICALS INC CO NBY | ARMISTICE CAPITAL LLC | 1,747,944 6.9% | 1,747,944 (New Position) | View |
2019-07-29 4:40 pm Purchase | 13G | NAKED BRAND GROUP LTD NAKD | ARMISTICE CAPITAL LLC | 6,752,000 8.2% | 4,126,890 (+157.21%) | View |
2019-07-03 12:59 pm Purchase | 13G | MALLINCKRODT PUB LTD CO SHS MNK | ARMISTICE CAPITAL LLC | 3,600,000 4.3% | 3,600,000 (New Position) | View |
2019-06-27 6:08 pm Purchase | 13G | AMAG PHARMACEUTICALS INC AMAG | ARMISTICE CAPITAL LLC | 4,000,000 11.8% | 655,000 (+19.58%) | View |
2019-06-24 4:58 pm Purchase | 13G | VANDA PHARMACEUTICALS INC VNDA | ARMISTICE CAPITAL LLC | 3,268,000 6.2% | 3,268,000 (New Position) | View |
2019-06-24 4:36 pm Unchanged | 13G | NAVIDEA BIOPHARMACEUTICALS INC NAVB | ARMISTICE CAPITAL LLC | 0 0% | 0 (Unchanged) | View |
2019-06-24 4:13 pm Purchase | 13D | RESHAPE LIFESCIENCES INC P RSLS | ARMISTICE CAPITAL LLC | 244,561,824 94.9% | 244,561,824 (New Position) | View |
2019-06-17 4:27 pm Purchase | 13G | REWALK ROBOTICS LTD SHS PAR $. LFWD | ARMISTICE CAPITAL LLC | 313,246 4.99% | 313,246 (New Position) | View |
2019-06-13 5:26 pm Sale | 13G | ACHIEVE LIFE SCIENCE INC N ACHV | ARMISTICE CAPITAL LLC | 640,000 8% | -455,926 (-41.60%) | View |
2019-06-10 5:23 pm Purchase | 13G | CTD HOLDINGS INC CTDH | ARMISTICE CAPITAL LLC | 12,000,000 9.9% | 12,000,000 (New Position) | View |
2019-06-07 5:07 pm Purchase | 13G | ACHIEVE LIFE SCIENCE INC N ACHV | ARMISTICE CAPITAL LLC | 1,095,926 13.7% | 647,926 (+144.63%) | View |
2019-06-05 2:59 pm Purchase | 13G | NOVUS THERAPEUTICS INC NVUS | ARMISTICE CAPITAL LLC | 657,647 4.99% | 657,647 (New Position) | View |
2019-06-03 5:21 pm Purchase | 13G | CERVOMED INC CRVO | ARMISTICE CAPITAL LLC | 256,516 5.5% | 256,516 (New Position) | View |
2019-06-03 5:17 pm Purchase | 13G | ONCOSEC MED INC PAR $0.000 ONCS | ARMISTICE CAPITAL LLC | 550,158 4.99% | 550,158 (New Position) | View |
2019-05-30 10:55 am Purchase | 13G | CAN-FITE BIOPHARMA LTD SPONSOR CANF | ARMISTICE CAPITAL LLC | 174,581 4.99% | 174,581 (New Position) | View |
2019-05-20 5:05 pm Purchase | 13G | AMAG PHARMACEUTICALS INC AMAG | ARMISTICE CAPITAL LLC | 3,345,000 9.9% | 1,467,000 (+78.12%) | View |